TickerFacts.

Boston Scientific Corp (BSX): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2012-12-31, 2015-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$3.66B
Year ended 2025-12-31
$3.62B
Trailing 12 months to 2026-06-30
+57.4%
3-year compound annual growth
+26.4%
5-year compound annual growth
+23.5%
10-year compound annual growth
2007-12-31: $571.00M2008-12-31: $854.00M2009-12-31: $523.00M2010-12-31: $53.00M2011-12-31: $704.00M2012-12-31: $1.05B2013-12-31: $865.00M2014-12-31: $1.01B2015-12-31: $444.00M2016-12-31: $806.00M2017-12-31: $1.11B2018-12-31: -$6.00M2019-12-31: $1.38B2020-12-31: $1.13B2021-12-31: $1.32B2022-12-31: $938.00M2023-12-31: $1.79B2024-12-31: $2.65B2025-12-31: $3.66B$3.66B
2007-12-31 Free Cash Flow (USD) 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31$3.66B+38.3%2026-02-17, From 2025-01-01
2024-12-31$2.65B+47.6%2026-02-17, From 2024-01-01
2023-12-31$1.79B+91.0%2026-02-17, From 2023-01-01
2022-12-31$938.00M-28.7%2025-02-18, From 2022-01-01
2021-12-31$1.32B+16.3%2024-02-20, From 2021-01-01
2020-12-31$1.13B-17.7%2023-02-23, From 2020-01-01
2019-12-31$1.38Bn/m2022-02-23, From 2019-01-01
2018-12-31-$6.00Mn/m2021-02-23, From 2018-01-01
2017-12-31$1.11B+37.3%2020-02-25, From 2017-01-01
2016-12-31$806.00M+81.5%2019-02-19, From 2016-01-01
2015-12-31$444.00Mn/c2018-02-20, From 2015-01-01
2014-12-31$1.01B+16.8%2017-02-23, From 2014-01-01
2013-12-31$865.00M-17.9%2016-02-24, From 2013-01-01
2012-12-31$1.05Bn/c2015-02-25, From 2012-01-01
2011-12-31$704.00Mn/m2014-02-26, From 2011-01-01
2010-12-31$53.00M-89.9%2013-02-22, From 2010-01-01
2009-12-31$523.00M-38.8%2012-02-17, From 2009-01-01
2008-12-31$854.00M+49.6%2011-02-17, From 2008-01-01
2007-12-31$571.00Mn/a2010-02-26, From 2007-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
Boston Scientific Corp (BSX)2025-12-31$3.66B+38.3%
Becton Dickinson & Co (BDX)2025-09-30$2.67B-14.4%
3M Co (MMM)2025-12-31$1.40B+118.8%
Stryker Corp (SYK)2025-12-31$4.28B+22.8%
Medline Inc. (MDLN)2025-12-31$1.30B-8.3%
Baxter International Inc (BAX)2025-12-31$332.00M-42.1%
Solventum Corp (SOLV)2025-12-31-$10.00Mn/m
ResMed Inc (RMD)2026-06-30$1.65B-0.7%
Dexcom Inc (DXCM)2025-12-31$1.08B+70.8%

Compare BSX, BDX, MMM, SYK side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗